Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Edoardo Migliori"'
Autor:
Mithil K. Soni, Edoardo Migliori, Jianing Fu, Amer Assal, Hei Ton Chan, Jian Pan, Prabesh Khatiwada, Rodica Ciubotariu, Michael S. May, Marcus R. Pereira, Valeria De Giorgi, Megan Sykes, Markus Y. Mapara, Pawel J. Muranski
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
T cell immunity plays a central role in clinical outcomes of Coronavirus Infectious Disease 2019 (COVID-19) and T cell-focused vaccination or cellular immunotherapy might provide enhanced protection for some immunocompromised patients. Pre-existing T
Externí odkaz:
https://doaj.org/article/b84e8a9f34fd4aeaa32bea55f2fadcc0
Autor:
Pushpamali De Silva, Soizic Garaud, Cinzia Solinas, Alexandre de Wind, Gert Van den Eyden, Vinu Jose, Chunyan Gu-Trantien, Edoardo Migliori, Anaïs Boisson, Céline Naveaux, Hugues Duvillier, Ligia Craciun, Denis Larsimont, Martine Piccart-Gebhart, Karen Willard-Gallo
Publikováno v:
EBioMedicine, Vol 39, Iss , Pp 226-238 (2019)
Background: FOXP1, a transcriptional regulator of lymphocyte development, is abnormally expressed in some human tumors. This study investigated FOXP1-mediated regulation of tumor infiltrating lymphocytes (TIL) in untreated primary breast cancer (BC).
Externí odkaz:
https://doaj.org/article/abec8ec94bac403a8e0f4ccc86990f3b
Autor:
Cinzia Solinas, Marco Aiello, Esdy Rozali, Matteo Lambertini, Karen Willard-Gallo, Edoardo Migliori
Publikováno v:
Translational Oncology, Vol 13, Iss 10, Pp 100811- (2020)
Programmed cell death-ligand 2 (PD-L2) is one of the two ligands of the programmed cell death-1 (PD-1) receptor, an inhibitory protein mainly expressed on activated immune cells that is targeted in the clinic, with successful and remarkable results.
Externí odkaz:
https://doaj.org/article/c424f8953128418eb64eb3ac9e5ef10e
Autor:
Diego Farinello, Monika Wozińska, Elisa Lenti, Luca Genovese, Silvia Bianchessi, Edoardo Migliori, Nicolò Sacchetti, Alessia di Lillo, Maria Teresa Sabrina Bertilaccio, Claudia de Lalla, Roberta Valsecchi, Sabrina Bascones Gleave, David Lligé, Cristina Scielzo, Laura Mauri, Maria Grazia Ciampa, Lydia Scarfò, Rosa Bernardi, Dejan Lazarevic, Blanca Gonzalez-Farre, Lucia Bongiovanni, Elias Campo, Andrea Cerutti, Maurilio Ponzoni, Linda Pattini, Federico Caligaris-Cappio, Paolo Ghia, Andrea Brendolan
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-12 (2018)
The stromal microenvironment plays a key role in the expansion of chronic lymphocytic leukemia. Here, the authors use the Eµ-TCL1 mouse model to show that leukemic B-cells induce the activation of retinoic acid synthesis in stromal cells of the lymp
Externí odkaz:
https://doaj.org/article/ae8a25dfa5e64465b221fe7111cbb8b6
Autor:
Cinzia Solinas, Soizic Garaud, Pushpamali De Silva, Anaïs Boisson, Gert Van den Eynden, Alexandre de Wind, Paolo Risso, Joel Rodrigues Vitória, François Richard, Edoardo Migliori, Grégory Noël, Hugues Duvillier, Ligia Craciun, Isabelle Veys, Ahmad Awada, Vincent Detours, Denis Larsimont, Martine Piccart-Gebhart, Karen Willard-Gallo
Publikováno v:
Frontiers in Immunology, Vol 8 (2017)
There is an exponentially growing interest in targeting immune checkpoint molecules in breast cancer (BC), particularly in the triple-negative subtype where unmet treatment needs remain. This study was designed to analyze the expression, localization
Externí odkaz:
https://doaj.org/article/c0ae6c7e6f8a480eaeb268412bf17aff
Autor:
Mireille Langouo Fontsa, Marco Maria Aiello, Edoardo Migliori, Mario Scartozzi, Matteo Lambertini, Karen Willard-Gallo, Cinzia Solinas
Publikováno v:
Targeted Oncology. 17:497-505
Patients with cancer are at an increased risk of venous (VTE) and arterial thromboembolism (ATE), and thromboembolic events (TEs) represent the second-leading cause of death in cancer patients. The risk of cancer-associated thromboembolism is multifa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::428be193391253bfe85d87728263d04b
https://doi.org/10.1007/s11523-022-00908-8
https://doi.org/10.1007/s11523-022-00908-8
Autor:
Mithil Soni, Edoardo Migliori, Jianing Fu, Amer Assal, Hei Ton Chan, Jian Pan, Prabesh Khatiwada, Rodica Ciubotariu, Michael S. May, Marcus Pereira, Valeria De Giorgi, Megan Sykes, Markus Y Mapara, Pawel Muranski
T cell immunity plays a central role in clinical outcomes of Coronavirus Infectious Disease 2019 (COVID-19). Therefore, T cell-focused vaccination or cellular immunotherapy might provide enhanced protection for immunocompromised patients. Pre-existin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::41d7e21927f35282fa9faf9d16723992
https://doi.org/10.1101/2023.01.03.519511
https://doi.org/10.1101/2023.01.03.519511
Autor:
Antonino Musolino, Chiara Tommasi, Karen Willard-Gallo, Pushpamali De Silva, Thilini Hemali Senevirathne, Daniele Farci, Edoardo Migliori, Olga Elisabetta Cursio, Benedetta Pellegrino, Cinzia Solinas, Mario Scartozzi, M. Schena
Publikováno v:
Seminars in Oncology. 48:208-225
In the recent years characterized by the cancer immunotherapy revolution, attention has turned to how to potentially boost and/or generate an efficient anti-tumor immune response in breast cancer (BC). Clinical activity of immune checkpoint blockade
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::979c8629970cb3cba406eae58b989052
https://doi.org/10.1053/j.seminoncol.2021.09.002
https://doi.org/10.1053/j.seminoncol.2021.09.002
Autor:
Cinzia Solinas, Marco Aiello, Karen Willard-Gallo, Chunyan Gu-Trantien, Edoardo Migliori, Pushpamali De Silva
Publikováno v:
International Journal of Cancer. 149:31-41
Immunotherapy approaches boosting spontaneous and durable antitumor immune responses through immune checkpoint blockade are revolutionizing treatment and patient outcomes in solid tumors and hematological malignancies. Among the various inhibitory mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e94d084bcd3452e6e52d4fd17c4f8a6
https://doi.org/10.1002/ijc.33415
https://doi.org/10.1002/ijc.33415
Publikováno v:
Cytokine & Growth Factor Reviews
Graphical abstract Physiology and pathophysiology of pulmonary alveoli during SARS-CoV-2 infection. (A) COVID-19 severity: frequency of degrees of clinical manifestations in a Chinese cohort (>44.000 patients) (ref: Wu Z. et al, 2020). (B) Phases of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4f5c2eff69bc52572c7968ee36c8696
https://doi.org/10.1016/j.cytogfr.2020.06.012
https://doi.org/10.1016/j.cytogfr.2020.06.012